Search research articles
Contact Us
Filters
Showing results (121-130 of 138) with videos related to
Page
of 14
Sort By:
British Journal of Cancer
|
January 11, 2014
Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial
E Samalin, O Bouché, S Thézenas, et al.
Toxicology Letters
|
January 26, 2021
Dose-dependent emergence of acute and recurrent corneal lesions in sulfur mustard-exposed rabbit eyes
Patrick M McNutt, Kyle E M Kelly, Amber C Altvater, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 10, 2024
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial
T Conroy, F Castan, P-L Etienne, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 27, 2005
An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32)
A Brédart, A Bottomley, J M Blazeby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy
P Rougier, R Bugat, J Y Douillard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 25, 2020
Corrigendum to An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45: Ann Oncol 2020; Volume 31, Issue 2, Pages 283-288
V Bjelic-Radisic, F Cardoso, D Cameron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2020
An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45
V Bjelic-Radisic, F Cardoso, D Cameron, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 25, 2019
Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS)
A Adenis, J Bennouna, P L Etienne, et al.
Tumori
|
July 25, 1998
Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group
J Wils, T Sahmoud, A Sobrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2017
Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer
D Azria, J Doyen, M Jarlier, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 138) with videos related to
Sort By:
Page
of 14
British Journal of Cancer
|
January 11, 2014
Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial
E Samalin, O Bouché, S Thézenas, et al.
Toxicology Letters
|
January 26, 2021
Dose-dependent emergence of acute and recurrent corneal lesions in sulfur mustard-exposed rabbit eyes
Patrick M McNutt, Kyle E M Kelly, Amber C Altvater, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 10, 2024
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial
T Conroy, F Castan, P-L Etienne, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 27, 2005
An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32)
A Brédart, A Bottomley, J M Blazeby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy
P Rougier, R Bugat, J Y Douillard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 25, 2020
Corrigendum to An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45: Ann Oncol 2020; Volume 31, Issue 2, Pages 283-288
V Bjelic-Radisic, F Cardoso, D Cameron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2020
An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45
V Bjelic-Radisic, F Cardoso, D Cameron, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 25, 2019
Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS)
A Adenis, J Bennouna, P L Etienne, et al.
Tumori
|
July 25, 1998
Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group
J Wils, T Sahmoud, A Sobrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2017
Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer
D Azria, J Doyen, M Jarlier, et al.
Page
of 14